Funding for this research was provided by:
Clinical Medical Research Center, National Cheng Kung University Hospital (NCKUH-10902042 and NCKUH-10706006)
National Science Council (NSC 101-2325-B-002-084, NSC 102-2325-B-002-080)
National Health Research Institutes (PD-101-SP-01, PD-102-SP-01)
Centers for Disease Control
Received: 7 August 2019
Accepted: 7 August 2020
First Online: 19 August 2020
Ethics approval and consent to participate
: The protocol of this study was reviewed and approved by the Institutional Review Board (IRB) of each hospital in TPIDA, and was also approved by the IRB of National Cheng Kung University Hospital (NCKU) (No. HR-98-112). The written informed consents were obtained from all participating patients prior to clinical data. The patients’ guardians got the informed consents form principal investigator and the written informed consents were delivered to the study co-ordinators form patients’ guardians.
: The submission of this manuscript has been approved by all authors. The patients have provided consent for publication: “The individuals in this manuscript have given written informed consent to publish these case details”.
: The authors declare that they have no competing interests.